CIK 0001653087 · Accelerated filer<br>Smaller reporting company
Alector, Inc.
Sign in to watch- Ticker
- ALEC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 822933343
- Phone
- 415-231-5660
- Business address
- 131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Alector LLC
- 8-K Event Other events
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market sale Chief Medical Officer sold 59,749 shares at an average $38.00 ($2,270,404)
- 4 Open-market sale Vice President, Finance sold 114,174 shares at an average $32.80 ($3,744,601)
- 4 Open-market sale Chief Development Officer sold 60,000 shares at $31.14 ($1,868,400)
- 8-K Event Material agreement · Regulation FD disclosure
- 4 Open-market sale Chief Medical Officer sold 56,726 shares at an average $26.94 ($1,528,324)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Medical Officer sold 34,600 shares at an average $22.08 ($764,002)
- 8-K Event Shareholder vote results
- 4 Open-market sale Chief Medical Officer sold 19,175 shares at an average $19.18 ($367,745)
- 4 Open-market sale Vice President, Finance sold 1,844 shares at $17.77 ($32,768)
- 4 Open-market sale Chief Medical Officer sold 14,975 shares at $18.14 ($271,681)
- 4 Open-market sale Chief Medical Officer sold 4,200 shares at $18.04 ($75,786)
Page 21 of 32 · 631 filings